Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
CALL
Amdocs
DOX
$6.18B
| $1.09M | ﹤0.01% |
16,700
+9,000
| +117% | +$584K |
|
|
PAY
4377
PUT
DELISTED
Verifone Systems Inc
PAY
| $1.09M | ﹤0.01% |
61,800
+17,500
| +40% | +$325K |
|
|
OA
4378
DELISTED
Orbital ATK, Inc.
OA
| $1.09M | ﹤0.01% |
8,308
-2,827
| -25% | -$375K |
|
4379
Magna International
MGA
$18.8B
| $1.09M | ﹤0.01% |
+19,261
| New | +$1.06M |
|
|
OPTU
4380
CALL
Optimum Communications Inc
OPTU
$251M
| $1.09M | ﹤0.01% |
+51,400
| New | +$1.14M |
|
4381
Celestica
CLS
$42.3B
| $1.09M | ﹤0.01% |
103,719
-94,613
| -48% | -$1.05M |
|
4382
CALL
WEX
WEX
$6.54B
| $1.09M | ﹤0.01% |
7,700
+2,600
| +51% | +$325K |
|
|
AERI
4383
PUT
DELISTED
Aerie Pharmaceuticals
AERI
| $1.09M | ﹤0.01% |
18,200
-35,000
| -66% | -$2.12M |
|
|
CHUY
4384
PUT
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.09M | ﹤0.01% |
38,700
-16,900
| -30% | -$400K |
|
|
EMWP
4385
PUT
DELISTED
Eros Media World PLC
EMWP
| $1.09M | ﹤0.01% |
5,625
+1,900
| +51% | +$468K |
|
|
GHY
4386
PGIM Global High Yield Fund
GHY
$478M
| $1.08M | ﹤0.01% |
+75,280
| New | +$1.1M |
|
4387
PUT
Myriad Genetics
MYGN
$290M
| $1.08M | ﹤0.01% |
31,600
-3,800
| -11% | -$128K |
|
4388
PUT
RPM International
RPM
$14.5B
| $1.08M | ﹤0.01% |
20,700
-29,900
| -59% | -$1.56M |
|
|
AVXS
4389
CALL
DELISTED
AveXis, Inc. Common Stock
AVXS
| $1.08M | ﹤0.01% |
9,800
-300
| -3% | -$30.1K |
|
4390
CALL
Iron Mountain
IRM
$38.5B
| $1.08M | ﹤0.01% |
28,700
-2,900
| -9% | -$115K |
|
|
BNCL
4391
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $1.08M | ﹤0.01% |
65,841
-25,055
| -28% | -$416K |
|
4392
PUT
IDEX
IEX
$17.6B
| $1.08M | ﹤0.01% |
+8,200
| New | +$1.06M |
|
|
SEM
4393
DELISTED
Select Medical
SEM
| $1.08M | ﹤0.01% |
113,580
-98,691
| -46% | -$943K |
|
4394
CALL
Zebra Technologies
ZBRA
$17.8B
| $1.08M | ﹤0.01% |
10,400
-2,300
| -18% | -$250K |
|
4395
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $1.08M | ﹤0.01% |
13,900
-1,400
| -9% | -$95.5K |
|
4396
CALL
Strategy Inc
MSTR
$36.6B
| $1.08M | ﹤0.01% |
82,000
-2,000
| -2% | -$26.9K |
|
4397
Lloyds Banking Group
LYG
$90.1B
| $1.08M | ﹤0.01% |
287,053
+134,011
| +88% | +$483K |
|
|
CLDT
4398
Chatham Lodging
CLDT
$605M
| $1.07M | ﹤0.01% |
47,250
-45,483
| -49% | -$1.02M |
|
4399
Gildan
GIL
$10.5B
| $1.07M | ﹤0.01% |
+33,273
| New | +$1.04M |
|
|
VER
4400
PUT
DELISTED
VEREIT, Inc.
VER
| $1.07M | ﹤0.01% |
27,600
+21,200
| +331% | +$850K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.